Read More Pharma Industry News Clinuvel Pharmaceuticals (ASX: CUV; Nasdaq: CUVL) reorganises around U.S. markets after Nasdaq debut Clinuvel Pharmaceuticals is aligning its organisation with an increasingly U.S.-centred commercial and clinical strategy, but the value of the reset will depend on measurable progress rather than greater Nasdaq visibility alone. bySrinathJuly 23, 2026